Menu
  • Join
  • Login
  • Contact
 

Search abstracts


APPROVAL AND DISCONTINUATION OF SYSTEMIC ANTIBACTERIAL DRUGS IN THE US(JANUARY1938- DECEMBER2018)

  • At: 2019 FIP Congress in AbuDhabi (United Arab Emirates)
  • Type: Poster
  • By: ALQAHTANI, Saad (Jazan University, Clinical Pharmacy, Saudi Arabia)
  • Co-author(s): Saad Saeed Alqahtani: Clinical Pharmacy Department, Jazan University, JAZAN, Saudi Arabia;Pharmacy Practice Research Unit, College of Pharmacy, Jazan University, JAZAN, Saudi Arabia
    Enrique Seoane-Vazquez: School of Pharmacy, Economic Science Institute, Chapman University, Irvine, CA, United States
    Rosa Rodriguez-Monguio: Department of Clinical Pharmacy, School of Pharmacy, University of California, San Francisco, San Francisco, CA, United States
    Abdulrhman Alsayri: Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha, Saudi Arabia
  • Abstract:

    Background

    Despite the clinical and economic importance of systemic antibacterial drugs, only a few studies have assessed short-term approvals and discontinuations of systemic antibacterials in the US.

    Methods

    Data were extracted from publicly available data on the FDA website: Drugs@FDA. The dates of approval and market status were confirmed using

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses